Literature DB >> 23395957

Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Courtney L Donica1, Hibah O Awwad, Deepak R Thakker, Kelly M Standifer.   

Abstract

The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor is the fourth and most recently discovered member of the opioid receptor superfamily that also includes μ, δ, and κ opioid receptor subtypes (MOR, DOR, and KOR, respectively). The widespread anatomic distribution of the NOP receptor enables the modulation of several physiologic processes by its endogenous agonist, N/OFQ. Accordingly, the NOP receptor has gained a lot of attention as a potential target for the development of ligands with therapeutic use in several pathophysiological states. NOP receptor activation frequently results in effects opposing classic opioid receptor action; therefore, regulation of the NOP receptor and conditions affecting its modulatory tone are important to understand. Mounting evidence reveals a heterologous interaction of the NOP receptor with other G protein-coupled receptors, including MOR, DOR, and KOR, which may subsequently influence their function. Our focus in this review is to summarize and discuss the findings that delineate the cellular mechanisms of NOP receptor signaling and regulation and the regulation of other receptors by N/OFQ and the NOP receptor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395957      PMCID: PMC3629824          DOI: 10.1124/mol.112.084632

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  136 in total

1.  Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain.

Authors:  S Clarke; Z Chen; M-S Hsu; R G Hill; J E Pintar; I Kitchen
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

2.  Recombinant roulette versus the apparent virtues of 'natural' cell receptor systems: receptor genotypes versus phenotypes.

Authors:  Terry Kenakin
Journal:  Trends Pharmacol Sci       Date:  2002-09       Impact factor: 14.819

3.  Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype.

Authors:  Ying-Xian Pan; Elizabeth Bolan; Gavril W Pasternak
Journal:  Biochem Biophys Res Commun       Date:  2002-09-27       Impact factor: 3.575

4.  Regulation of STAT3 activity by G16-coupled receptors.

Authors:  Eddy H T Wu; Rico K H Lo; Yung H Wong
Journal:  Biochem Biophys Res Commun       Date:  2003-04-11       Impact factor: 3.575

5.  Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.

Authors:  D R Thakker; K M Standifer
Journal:  Neuropharmacology       Date:  2002-11       Impact factor: 5.250

6.  Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.

Authors:  Yoshio Hashimoto; Girolamo Calo'; Remo Guerrini; Graham Smith; David G Lambert
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

7.  Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells.

Authors:  Jamshid Arjomand; Steve Cole; Chris J Evans
Journal:  J Neuroimmunol       Date:  2002-09       Impact factor: 3.478

8.  Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Authors:  Christopher W Vaughan; Elena E Bagley; Geoffrey M Drew; Alwin Schuller; John E Pintar; Stephen P Hack; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells.

Authors:  S Spampinato; R Di Toro; M Alessandri; G Murari
Journal:  Cell Mol Life Sci       Date:  2002-12       Impact factor: 9.261

10.  Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.

Authors:  Deepak R Thakker; Kelly M Standifer
Journal:  Brain Res Mol Brain Res       Date:  2002-09-30
View more
  11 in total

1.  Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma.

Authors:  Shailendra R Singh; Nikol Sullo; Maria Matteis; Giuseppe Spaziano; John McDonald; Ruth Saunders; Lucy Woodman; Konrad Urbanek; Antonella De Angelis; Raffaele De Palma; Rachid Berair; Mitesh Pancholi; Vijay Mistry; Francesco Rossi; Remo Guerrini; Girolamo Calò; Bruno D'Agostino; Christopher E Brightling; David G Lambert
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

2.  NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.

Authors:  Anna Maria Borruto; Yannick Fotio; Serena Stopponi; Gloria Brunori; Michele Petrella; Francesca Felicia Caputi; Patrizia Romualdi; Sanzio Candeletti; Rajesh Narendran; Linda M Rorick-Kehn; Massimo Ubaldi; Friedbert Weiss; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 3.  Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.

Authors:  Joseph Pergolizzi; Peter Magnusson; Flaminia Coluzzi; Frank Breve; Jo Ann K LeQuang; Giustino Varrassi
Journal:  Cureus       Date:  2022-06-16

Review 4.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

5.  An atlas of neural crest lineages along the posterior developing zebrafish at single-cell resolution.

Authors:  Aubrey Ga Howard; Phillip A Baker; Rodrigo Ibarra-García-Padilla; Joshua A Moore; Lucia J Rivas; James J Tallman; Eileen W Singleton; Jessa L Westheimer; Julia A Corteguera; Rosa A Uribe
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

6.  Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.

Authors:  James J Lu; Willma E Polgar; Anika Mann; Pooja Dasgupta; Stefan Schulz; Nurulain T Zaveri
Journal:  Mol Pharmacol       Date:  2021-05-06       Impact factor: 4.054

7.  The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.

Authors:  Francesca Felicia Caputi; Elio Acquas; Sanjay Kasture; Stefania Ruiu; Sanzio Candeletti; Patrizia Romualdi
Journal:  BMC Complement Altern Med       Date:  2018-01-10       Impact factor: 3.659

Review 8.  Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.

Authors:  Jong Yung Park; Suji Chae; Chang Seop Kim; Yoon Jae Kim; Hyun Joo Yi; Eunjoo Han; Youngshin Joo; Surim Hong; Jae Won Yun; Hyojung Kim; Kyung Ho Shin
Journal:  Korean J Physiol Pharmacol       Date:  2019-10-24       Impact factor: 2.016

Review 9.  Biased Opioid Ligands.

Authors:  Abdelfattah Faouzi; Balazs R Varga; Susruta Majumdar
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

Review 10.  Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.

Authors:  Claes Wahlestedt; Olga Khorkova
Journal:  Cell Mol Neurobiol       Date:  2020-07-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.